Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05897658 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Levetiracetam Prophylaxis in Brain Tumor Resection Pilot

Study acronym: LeviTaTe Pilot
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 23, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Jul 2024 to Mar 2026
    • Start date: Jun 2024 to Mar 2025
    v4
  2. Start date: Dec 2023 to Jun 2024v3
  3. Start date: Jul 2023 to Dec 2023v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate feasibility of a double-blind randomized controlled trial for levetiracetam prophylaxis for prevention of seizure in the perioperative phase of brain tumor resection.
Trial Details
NCT Number NCT05897658
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: McMaster University
Conditions
(from sponsor)		 Seizures, Brain Tumor
Related terms Brain Neoplasms, Seizures
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov